Advance Auto Parts, Inc. vs ADMA Biologics Inc — how do they compare? Advance Auto Parts, Inc. trades at $53.1 (market cap $3.36B), while ADMA Biologics Inc trades at $9.81 (market cap $2.18B). The key difference: Advance Auto Parts, Inc. is the larger of the two by market cap, and Advance Auto Parts, Inc. pays a 1.79% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| AAP | ADMA | |
|---|---|---|
Market Cap | $3.36B | $2.18B |
Sector | Consumer Cyclical | Health |
52-Week High | $64.17 | $20.38 |
52-Week Low | $38.75 | $7.60 |
Enterprise Value | $5.63B | $2.25B |
Dividend Yield | 1.79% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ADMA trades at $9.90, down 1.59% today, with strong profitability metrics including 64.71% gross margin and 41.9% ROE. Technical indicators show a bullish trend with support at $9-10, though RSI levels suggest overbought conditions. Recent earnings show mixed results with Q4 2025 beating expectations but Q1 and Q2 2026 missing estimates. The stock faces significant legal headwinds with multiple securities fraud lawsuits filed against the company.
Despite strong fundamentals and bullish analyst consensus (88.9% buy ratings), ADMA faces substantial legal risks from ongoing securities litigation that could impact shareholder value. The company's solid profit margins and growth trajectory provide upside potential, but investors should carefully weigh litigation risks against fundamental strength.
Trailing returns across standard periods
Advance Auto Parts is one of the industry's largest retailers of aftermarket automotive parts, tools, and accessories to do-it-yourself customers in North America. Advance operated 4,972 stores as of the end of 2021, in addition to servicing 1,317 independently owned Carquest stores. The company's Worldpac unit is a premier distributor of imported original-equipment parts. Advance derived 58% of its 2021 sales from commercial clients, up from 30%-40% before the General Parts deal.
Read more on AAP →ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →